Cargando…
Leishmania tarentolae novel responses to Bi(3+)-doped strontium aluminum oxyfluorides
Novel therapeutics for the treatment of leishmaniasis are of interest as the disease not only is becoming more prevalent, but drug resistance is increasing in certain regions of the world. Reported here is the use of Bi(3+)-doped strontium aluminum oxyfluoride phosphors and protease inhibitors to te...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414179/ https://www.ncbi.nlm.nih.gov/pubmed/34504976 http://dx.doi.org/10.1016/j.heliyon.2021.e07896 |